JAMA Health Forum Conversations cover art

All Episodes

JAMA Health Forum Conversations — 65 episodes

#
Title
1

Policy Approaches to Securing an Adequate Nursing Workforce for Years to Come

2

Aging America: Policy, Workforce, and the Future of Long-Term Care

3

Science Bearing Witness in a Post-Dobbs World

4

The Year We Lost Medicaid

5

Keeping Health Equity at the Forefront of the AI Revolution

6

Market-Based Solutions to Improve US Health Care

7

In Search of US Pharmaceutical Policy Innovation

8

The Future of Primary Care in the US

9

Changes in Policy and the Health of LGBTQ+ Populations

10

The Centrality of Women's Health to a Population Health Research Agenda

11

National Policy to Support Better Mental Health in the US

12

The Impact of Nonhealth Policies in a Time of Policy Disruption

13

The Evolution of Artificial Intelligence and Regulation

14

Improving Health and Health Care Affordability in the US with David Cutler

15

The Threat to Health Insurance Coverage in the US

16

The Potential Repercussions of Disinvestment in Health in the US

17

The US, the World Health Organization, and a New Era in Global Health

18

What's Next for JAMA Health Forum and for Health Policy?

19

Farewell Conversation With JAMA Health Forum Founding Editor in Chief John Ayanian

20

Impact of US Tobacco 21 Policies on Potential Mortality Reductions by State

21

Extreme Heat Health Consequences

22

Physician Altruism and Quality of Care

23

Health Care–Related Savings Accounts, Health Care Expenditures, and Tax Expenditures

24

Highlights From the AcademyHealth 2024 Annual Research Meeting

25

Health Care–Based Voter Registration: A New Venue to Increase Voter Participation

26

Differences in Services Provided at Public and Nonprofit Hospitals Related to the 340B Drug Discount Program

27

Measuring Medicaid Enrollment More Accurately to Guide Post–COVID-19 Pandemic Policy

28

Comparing Home Health Services in Traditional Medicare and Medicare Advantage

29

Changes in Access to Care and Preventive Services by Race and Ethnicity During the COVID-19 Pandemic

30

Opioid Prescription Duration Limits

31

Trends in Smoking Among US Adults From 2011 to 2022

32

The History, Economics, and Policy Context of Pharmacy Benefit Managers

33

Economic Burden of Untreated Mental Illness in Indiana

34

Innovative Approach to Promote Equitable Access to COVID-19 Preventive Therapy

35

How Safe Were Kids in School During Phases of the Pandemic?

36

FDA Advisory Committees for New Prescription Drugs

37

Challenges of Addressing Food and Housing Insecurity in a Medicaid Context

38

Health Care Use and Spending Among Dual-Eligible Medicare and Medicaid Beneficiaries

39

Quality of Care and Visit Volume in Federally Qualified Health Centers During COVID-19

40

Best Practice in Adjusting For Social Risk

41

Predicting Future Malpractice Claims

42

Use of Mental Health Services During the COVID-19 Pandemic

43

Factors Contributing to the Slowdown in Medicare Spending Growth

44

Increased Food Insufficiency in Households With Children

45

Helping People Enroll in Marketplace Plans

46

Receipt of Out-of-State Telemedicine Visits Among Medicare Beneficiaries During the COVID-19 Pandemic

47

Prescription Drug Cost Provisions of the Inflation Reduction Act

48

Migration and Mortality Among Patients With Kidney Failure After Hurricane Maria in Puerto Rico

49

Does Rewarding Better Patient Care Experience Punish Safety-net Hospitals?

50

A Conversation With Dr Kirsten Bibbins-Domingo, JAMA's New Editor in Chief

51

Spillover Benefits of Medicaid Expansion for Older Adults

52

Advancing COVID-19 Research in a Learning Health Care System

53

Health Care Job Loss During the Pandemic

54

COVID-19 Vaccinations for California Prison Staff

55

Medicaid Policy Associated With Increased Enrollment During the Pandemic

56

Health System Factors Related to Overuse of Health Services in Medicare

57

Unequal Burdens of Cost Sharing for Medicare Beneficiaries

58

US Share of Insulin Expenditures Going to Pharmaceutical Manufacturers and Intermediaries

59

Medicaid Use and Spending for Drugs With FDA Accelerated Approval

60

New Evidence on the Effects of the COVID-19 Pandemic on Health Insurance Coverage

61

Self-reported Access to Firearms Among Patients Receiving Care for Mental Health and Substance Use

62

COVID-19's Shock to Health Care Services

63

Time and Financial Costs for Physician Practices Participating in MIPS

64

Alternative Health Care Payment Models—The Case for A Portfolio Strategy

65

Welcome to the JAMA Health Forum Editors' Summary